HIDRADENITIS SUPPURATIVA (HS)
Clinical trials for HIDRADENITIS SUPPURATIVA (HS) explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA (HS) trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA (HS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for painful skin condition in major trial
Disease control CompletedThis study tested a new drug called povorcitinib in 619 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and tunnels. For the first 12 weeks, some participants received the drug and others a placebo to see if it reduces skin…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
New pill shows promise for painful skin condition
Disease control CompletedThis study tested an experimental drug called povorcitinib in 608 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and tunnels under the skin. The goal was to see if the drug could reduce the number of painful bumps and drai…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 08:00 UTC
-
New dressing combo may help heal painful HS wounds
Symptom relief CompletedThis study tested a special wound dressing (a mix of methylene blue, gentian violet, and sheep stomach tissue) on 5 adults with hidradenitis suppurativa who had sores that wouldn't heal. The goal was to see how much the wounds shrank over 8 weeks and if pain improved. The dressin…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
AI boosts doctor accuracy for rare skin conditions
Knowledge-focused CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors more accurately diagnose rare and tricky skin conditions like generalized pustular psoriasis (GPP). Fifteen general practitioners and dermatologists reviewed 100 skin images, first giving their own …
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated May 17, 2026 08:02 UTC
-
AI boosts skin diagnosis accuracy for family doctors, small study finds
Knowledge-focused CompletedThis study tested whether an artificial intelligence (AI) tool could help primary care doctors more accurately diagnose skin conditions like melanoma, psoriasis, and eczema. Nine doctors reviewed 30 skin images, first giving a diagnosis on their own, then with the AI's suggestion…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC
-
Scientists hunt for skin clues in painful HS condition
Knowledge-focused CompletedThis study compared skin samples from 15 people with hidradenitis suppurativa (HS) and 15 healthy volunteers. Researchers measured the activity of specific genes and proteins linked to inflammation. The goal was to better understand what causes HS and find possible markers of dis…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Sponsor: Trakya University • Aim: Knowledge-focused
Last updated May 04, 2026 16:18 UTC